55 related articles for article (PubMed ID: 17716779)
1. Randomized phase II trial of three intrapleural therapy regimens for the management of malignant pleural effusion in previously untreated non-small cell lung cancer: JCOG 9515.
Yoshida K; Sugiura T; Takifuji N; Kawahara M; Matsui K; Kudoh S; Takada M; Fukuoka M; Ariyoshi Y; Fukuda H; Saijo N
Lung Cancer; 2007 Dec; 58(3):362-8. PubMed ID: 17716779
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant immunotherapy with intrapleural Streptococcus pyogenes (OK-432) in lung cancer patients after resection.
Lee YC; Luh SP; Wu RM; Lee CJ
Cancer Immunol Immunother; 1994 Oct; 39(4):269-74. PubMed ID: 7954529
[TBL] [Abstract][Full Text] [Related]
3. Phase2 study of bevacizumab with carboplatin-paclitaxel for non-small cell lung cancer with malignant pleural effusion.
Tamiya M; Tamiya A; Yamadori T; Nakao K; Asami K; Yasue T; Otsuka T; Shiroyama T; Morishita N; Suzuki H; Okamoto N; Okishio K; Kawaguchi T; Atagi S; Kawase I; Hirashima T
Med Oncol; 2013; 30(3):676. PubMed ID: 23925664
[TBL] [Abstract][Full Text] [Related]
4. Intrapleural Administration With Rh-Endostatin and Chemical Irritants in the Control of Malignant Pleural Effusion: A Systematic Review and Meta-Analysis.
Wang CQ; Huang XR; He M; Zheng XT; Jiang H; Chen Q; Fan TY; Zhan L; Ling J; Feng JH; Xiao X; Chen XF; Xiao Z
Front Oncol; 2021; 11():649999. PubMed ID: 34414103
[TBL] [Abstract][Full Text] [Related]
5. A Comparison of the Efficacies of OK-432 and Talc Slurry for Pleurodesis in Patients with Prolonged Air Leak after Pulmonary Resection.
Watanabe T; Yamauchi Y; Takeyama R; Kohmaru S; Dejima H; Saito Y; Sakao Y
Ann Thorac Cardiovasc Surg; 2024 Jan; 30(1):. PubMed ID: 37648484
[TBL] [Abstract][Full Text] [Related]
6. Intrapleural treatment in patients with non-small cell lung cancer with malignant pleural effusions in the real world.
Pan P; Wu F; Xu Z; Ji X; Qi Q; Huang X; Zhao R; Liu M; Jiang P; Li Y; Xu L
Thorac Cancer; 2021 Dec; 12(24):3416-3425. PubMed ID: 34741494
[TBL] [Abstract][Full Text] [Related]
7. Narrative review of theoretical considerations regarding HITHOC between past and future.
Molnar TF; Drozgyik A
Ann Transl Med; 2021 Jun; 9(11):954. PubMed ID: 34350269
[TBL] [Abstract][Full Text] [Related]
8. Phase 2 study of bevacizumab plus carboplatin/nab-paclitaxel followed by bevacizumab plus nab-paclitaxel for non-squamous non-small cell lung cancer with malignant pleural effusion.
Tamiya M; Tamiya A; Suzuki H; Taniguchi Y; Katayama K; Minomo S; Nakao K; Takeuchi N; Matsuda Y; Naito Y; Shiroyama T; Okamoto N; Okishio K; Kumagai T; Atagi S; Imamura F; Hirashima T
Invest New Drugs; 2021 Aug; 39(4):1106-1112. PubMed ID: 33544282
[TBL] [Abstract][Full Text] [Related]
9. Bevacizumab plus chemotherapy in nonsquamous non-small cell lung cancer patients with malignant pleural effusion uncontrolled by tube drainage or pleurodesis: A phase II study North East Japan Study group trial NEJ013B.
Noro R; Kobayashi K; Usuki J; Yomota M; Nishitsuji M; Shimokawa T; Ando M; Hino M; Hagiwara K; Miyanaga A; Seike M; Kubota K; Gemma A;
Thorac Cancer; 2020 Jul; 11(7):1876-1884. PubMed ID: 32421226
[TBL] [Abstract][Full Text] [Related]
10. Interventions for the management of malignant pleural effusions: a network meta-analysis.
Dipper A; Jones HE; Bhatnagar R; Preston NJ; Maskell N; Clive AO
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD010529. PubMed ID: 32315458
[TBL] [Abstract][Full Text] [Related]
11. Intracavitary chemotherapy with epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) is not superior to TKI monotherapy in controlling malignant pleural effusion recurrence in
Wang W; Jiang X; Zhang Y; Song Y; Song Z
J Thorac Dis; 2019 Sep; 11(9):3712-3720. PubMed ID: 31656643
[TBL] [Abstract][Full Text] [Related]
12. Talc pleurodesis for secondary pneumothorax in elderly patients with persistent air leak.
Watanabe T; Fukai I; Okuda K; Moriyama S; Haneda H; Kawano O; Yokota K; Shitara M; Tatematsu T; Sakane T; Oda R; Nakanishi R
J Thorac Dis; 2019 Jan; 11(1):171-176. PubMed ID: 30863586
[TBL] [Abstract][Full Text] [Related]
13. Development of a radionuclide-labeled monoclonal anti-CD55 antibody with theranostic potential in pleural metastatic lung cancer.
Dho SH; Kim SY; Chung C; Cho EH; Lee SY; Kim JY; Kim LK; Min SW; Lee J; Jung SH; Lim JC
Sci Rep; 2018 Jun; 8(1):8960. PubMed ID: 29895866
[TBL] [Abstract][Full Text] [Related]
14. Risk Factors for Chest Pain and Fever in Patients Undergoing Pleurodesis with OK-432.
Morimoto Y; Takei H; Tachibana K; Nakazato Y; Tanaka R; Nagashima Y; Watanabe K; Seki R; Shinohara T; Kondo H
Intern Med; 2018 Jun; 57(12):1697-1702. PubMed ID: 29434153
[TBL] [Abstract][Full Text] [Related]
15. Chemical Pleurodesis Using Doxycycline and
Song KS; Keum D; Kim JB
Korean J Thorac Cardiovasc Surg; 2017 Aug; 50(4):281-286. PubMed ID: 28795034
[TBL] [Abstract][Full Text] [Related]
16. Interstitial Lung Disease after Pleurodesis for Malignant Pleural Effusion.
Yokoe N; Katsuda E; Kosaka K; Hamanaka R; Matsubara A; Nishimura M; Tanaka H; Asai N; Takahashi A; Kawamura T; Ishiguchi T; Yamaguchi E; Kubo A
Intern Med; 2017; 56(14):1791-1797. PubMed ID: 28717073
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes of cytoreductive surgery combined with intrapleural perfusion of hyperthermic chemotherapy in advanced lung adenocarcinoma with pleural dissemination.
Yi E; Kim D; Cho S; Kim K; Jheon S
J Thorac Dis; 2016 Jul; 8(7):1550-60. PubMed ID: 27499943
[TBL] [Abstract][Full Text] [Related]
18. Interventions for the management of malignant pleural effusions: a network meta-analysis.
Clive AO; Jones HE; Bhatnagar R; Preston NJ; Maskell N
Cochrane Database Syst Rev; 2016 May; 2016(5):CD010529. PubMed ID: 27155783
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
